Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: The Hoorn study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 10, 2012, Pages 883-889

  Pilz, S ^a,b   van den Hurk, K ^a   Nijpels, G ^b   Stehouwer, C D A ^c   van't Riet, E ^b   Kienreich, K ^a   Tomaschitz, A ^a   Dekker, J M ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Diabetes; Follow up; Glucose metabolism; HbA1c; Prospective; Vitamin D

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; VITAMIN D;

AGED; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84866047943     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.03.008     Document Type: Article

References (40)

1. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
2. Pilz S., Tomaschitz A., März W., Drechsler C., Ritz E., Zittermann A., et al. Vitamin D, cardiovascular disease and mortality. Clin Endocinol (Oxf) 2011, 75:575-584.
3. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Reviews 2008, 29:726-776.
4. Messenger W, Nielson CM, Li H, Beer T, Barrett-Connor E, Stone K, et al. Serum and dietary vitamin D and cardiovascular risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis, epub ahead of print.
5. Rendina D., De Filippo G., Strazzullo P. Should vitamin D status be assessed in patients with congestive heart failure?. Nutr Metab Cardiovasc Dis 2010, 20:627-632.
6. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis, epub ahead of print.
7. Cavalier E., Delanaye P., Souberbielle J.C., Radermecker R.P. Vitamin D and type 2 diabetes mellitus. Where do we stand?. Diabet Metab 2011, 37:265-272.
8. Muscogiuri G., Sorice G.P., Ajjan R., Mezza T., Pilz S., Priolette A., et al. Can vitamin D deficiency cause diabetes and cardiovascular disease? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis 2012, 22:81-87.
9. Robinson J.G., Manson J.E., Larson J., Liu S., Song Y., Howard B.V., et al. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care 2011, 34:628-634.
10. Pittas A.G., Sun Q., Manson J.E., Dawson-Hughes B., Hu F.B. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 2010, 33:2021-2023.
11. Dalgård C., Petersen M.S., Weihe P., Grandjean P. Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians. Diabetes Care 2011, 34:1284-1288.
12. Mitri J., Muraru M.D., Pittas A.G. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011, 65:1005-1015.
13. Gagnon C., Lu Z.X., Magliano D.J., Dunstan D.W., Shaw J.E., Zimmet P.Z., et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011, 34:1133-1138.
14. Grimnes G., Emaus N., Joakimsen R.M., Figenschau Y., Jenssen T., Njølstad I., et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 2010, 27:1107-1115.
15. Knekt P., Laaksonen M., Mattila C., Härkänen T., Marniemi J., Heliövaara M., et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008, 19:666-671.
16. Liu E., Meigs J.B., Pittas A.G., Economos C.D., McKeown N.M., Booth S.L., et al. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 2010, 91:1627-1633.
17. Forouhi N.G., Luan J., Cooper A., Boucher B.J., Wareham N.J. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008, 57:2619-2625.
18. Liu E., McKeown N.M., Pittas A.G., Meigs J.B., Economos C.D., Booth S.L., et al. Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study. Eur J Clin Nutr 2012, 66:139-141.
19. Kayaniyil S., Retnakaran R., Harris S.B., Vieth R., Knight J.A., Gerstein H.C., et al. Prospective associations of vitamin D with {beta}-cell function and glycemia: the prospective metabolism and islet cell evaluation (PROMISE) cohort study. Diabetes 2011, 60:2947-2953.
20. Pilz S., Dobnig H., Nijpels G., Heine R.J., Stehouwer C.D., Snijder M.B., et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009, 71:666-672.
21. van den Berg E., Biessels G.J., Stehouwer C.D., Kappelle L.J., Heine R.J., Nijpels G., et al. Ten-year time course of risk factors for increased carotid intima-media thickness: the Hoorn study. Eur J Cardiovasc Prev Rehabil 2010, 17:168-174.
22. Lapolla A., Mosca A., Fedele D. The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. Nutr Metab Cardiovasc Dis 2011, 21:467-475.
23. Wendel-Vos G.C., Schuit A.J., Saris W.H., Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003, 56:1163-1169.
24. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
25. Gulseth H.L., Gjelstad I.M., Tierney A.C., Lovegrove J.A., Defoort C., Blaak E.E., et al. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 2010, 33:923-925.
26. Kositsawat J., Freeman V.L., Gerber B.S., Geraci S. Association of A1C levels with vitamin D status in U.S. adults: data from the National Health and Nutrition Examination Survey. Diabetes Care 2010, 33:1236-1238.
27. Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, et al. Association of HbA(1c) levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia, epub ahead of print.
28. Mitri J., Dawson-Hughes B., Hu F.B., Pittas A.G. Effects of vitamin D and calcium supplementation on pancreatic {beta} cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011, 94:486-494.
29. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30:980-986.
30. von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010, 103:549-555.
31. Zittermann A., Frisch S., Berthold H.K., Götting C., Kuhn J., Kleesiek K., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89:1321-1327.
32. Avenell A., Cook J.A., MacLennan G.S., McPherson G.C. RECORD trial group. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2009, 38:606-609.
33. de Boer I.H., Tinker L.F., Connelly S., Curb J.D., Howard B.V., Kestenbaum B., et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008, 31:701-707.
34. Jorde R., Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 2009, 48:349-354.
35. Nagpal J., Pande J.N., Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009, 26:19-27.
36. Grimnes G., Figenschau Y., Almås B., Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011, 60:2748-2757.
37. Pilz S., Tomaschitz A., Drechsler C., Ritz E., Boehm B.O., Grammer T.B., et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010, 31:1591-1598.
38. Zhao G., Ford E.S., Li C. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care 2010, 33:344-347.
39. McCarty M.F., Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003, 61:535-542.
40. Jorde R., Sneve M., Hutchinson M., Emaus N., Figenschau Y., Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010, 171:903-908.